Pulse Biosciences (PLSE) Other Accumulated Expenses (2015 - 2026)

Pulse Biosciences' Other Accumulated Expenses history runs 11 years deep, the most recent figure standing at $363000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 93.09% year-over-year to $363000.0; the TTM figure through Dec 2025 stood at $363000.0 (up 93.09% YoY), while the FY2025 annual figure was $363000.0, up 93.09% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $363000.0, up from $351000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $2.2 million in Q1 2021, with the low at $167000.0 in Q2 2024.
• The 5-year median for Other Accumulated Expenses is $213500.0 (2022), against an average of $348550.0.
• The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses surged 1786.21% in 2021, then slumped 86.52% in 2022.
• Pulse Biosciences' Other Accumulated Expenses stood at $513000.0 in 2021, then sank by 58.09% to $215000.0 in 2022, then decreased by 12.56% to $188000.0 in 2023, then changed by 0.0% to $188000.0 in 2024, then soared by 93.09% to $363000.0 in 2025.
• Business Quant data shows PLSE's Other Accumulated Expenses at $363000.0 in Q4 2025, $351000.0 in Q3 2025, and $212000.0 in Q2 2025.